How PerkinElmer is Helping Combat COVID-19

publication date: May 26, 2020
 | 
author/source: PerkinElmer

how-perkinelmer-helping-combat-covid19


Enabling science is vital in the fight against COVID-19.

PerkinElmer, Inc. is actively working with our global customers – which include specialty and reference diagnostic labs, clinics, hospitals, pharmaceutical and biopharmaceutical labs, academia, and governmental and research institutes – to combat the pandemic. Our innovative detection, workflow, and research solutions are being used to drive better outcomes as the world responds to COVID-19.

PerkinElmer is now the only company that has RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing, all from one vendor.

 

Testing

PerkinElmer is providing both serological and RT-PCR testing solutions for laboratories across the globe:

Serological

 

RT-PCR Test and Extraction

 

Workflows

The breadth of PerkinElmer’s total workflow solutions enables clinical diagnostics customers to rapidly process samples at high volumes: 

 

Critical Solutions for Research and Analysis

For pharmaceutical laboratories studying new drugs and vaccines or potentially repurposing existing drugs for COVID-19, PerkinElmer provides a variety of instruments, reagents, software and services -- from molecular, immune and pathogen research to sample automation and pharma manufacturing, and QA/QC. These include:

 

Our Solutions in Action

Our COVID-19 solutions have been implemented by renowned research institutions across the globe, including laboratories affiliated with Baylor University, Medical College of Georgia, Rutgers, University of Buffalo, and one of the largest research laboratories in Brazil.

 

About PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index.

 

more news from PerkinElmer



If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.